Search for Clinical Trial Results
Leukemia, Basophilic, Acute - 25 Studies Found
Status | Study |
Terminated |
Study Name: 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer Condition:
|
Terminated |
Study Name: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia Condition:
|
Completed |
Study Name: Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: XK469R in Treating Patients With Refractory Hematologic Cancer Condition:
|
Terminated |
Study Name: Cilengitide in Treating Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition:
|
Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition:
|
Terminated |
Study Name: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders Condition:
|